Patents by Inventor Cynthia Tuthill

Cynthia Tuthill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of Treating or Preventing Tissue Deterioration, Injury or Damage Due to Disease of Mucosa
    Publication number: 20110117211
    Abstract: An immunomodulatory compound is utilized to treat mucosa disease.
    Type: Application
    Filed: January 25, 2011
    Publication date: May 19, 2011
    Applicant: SCICLONE PHARMACEUTICALS, INC.
    Inventors: Israel RIOS, Cynthia TUTHILL
  • Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa
    Patent number: 7906486
    Abstract: An immunomodulatory compound is utilized to treat mucosa disease.
    Type: Grant
    Filed: February 11, 2008
    Date of Patent: March 15, 2011
    Assignee: SciClone Pharmaceuticals, Inc.
    Inventors: Israel Rios, Cynthia Tuthill
  • METHOD OF TREATING OR PREVENTING TISSUE DETERIORATION, INJURY OR DAMAGE DUE TO DISEASE OF MUCOSA
    Publication number: 20100086622
    Abstract: An immunomodulatory compound is utilized to treat mucosa disease.
    Type: Application
    Filed: February 11, 2008
    Publication date: April 8, 2010
    Applicant: SCICLONE PHARMACEUTICALS, INC.
    Inventors: Israel Rios, Cynthia Tuthill
  • TREATMENT OR PREVENTION OF RESPIRATORY VIRAL INFECTIONS WITH IMMUNOMODULATOR COMPOUNDS
    Publication number: 20070087974
    Abstract: An immunomodulatory compound is administered to a patient having, or at risk of a respiratory viral infection.
    Type: Application
    Filed: November 9, 2006
    Publication date: April 19, 2007
    Applicant: SCICLONE PHARMACEUTICALS, INC.
    Inventors: Cynthia TUTHILL, Alfred RUDOLPH, Alexander KOLOBOV, Andrey SIMBIRTSEV, Aleksandr PETROV
  • Treatment or prevention of respiratory viral infections with alpha thymosin peptides
    Publication number: 20070036744
    Abstract: An alpha thymosin peptide is administered to a patient having, or at risk of a respiratory viral infection, coronavirus infection and/or SARS.
    Type: Application
    Filed: April 23, 2004
    Publication date: February 15, 2007
    Applicant: SciClone Pharmaceuticals, Inc.
    Inventors: Alfred Rudolph, Cynthia Tuthill
  • Methods of protecting against radiation damage using alpha thymosin
    Publication number: 20060166877
    Abstract: Damage to cells and/or a subject caused by radiation is treated or prevented by administration of an alpha thymosin peptide.
    Type: Application
    Filed: November 25, 2003
    Publication date: July 27, 2006
    Applicant: SciClone Pharmaceticals, Inc.
    Inventors: Alfred Rudolph, Cynthia Tuthill
  • Pharmaceutical formulations comprising substituted xanthine compounds
    Publication number: 20060052404
    Abstract: The present invention provides novel pharmaceutical compositions comprising substituted xanthine compounds useful for the treatment of cystic fibrosis and other diseases, and methods of use thereof.
    Type: Application
    Filed: October 3, 2002
    Publication date: March 9, 2006
    Inventors: Alfred Rudolph, Cynthia Tuthill
  • Method of administering a thymosin alpha 1 peptide
    Publication number: 20050049191
    Abstract: A Thymosin alpha 1 (TA1) peptide is administered to a patient in need of immune stimulation so as to substantially continuously maintain an immune stimulating-effective amount of the TA1 peptide in the patient. The administration method may be by continuous infusion.
    Type: Application
    Filed: November 1, 2002
    Publication date: March 3, 2005
    Applicant: SicClone Pharmaceuticals, Inc.
    Inventors: Alfred Rudolph, Cynthia Tuthill